Clinical and functional characteristics of patients prior to lung transplantation: Report of experience at the Clínica Puerta de Hierro;Características clínicas y funcionales antes del trasplante pulmonar. Experiencia en la Clínica Puerta de Hierro

Archivos de Bronconeumologia

Volumn 44, Issue 8, 2008, Pages 424-427

  Laporta, Rosalía ^a,b   Ussetti, Piedad ^a   Mora, Gema ^a   López, Cristina ^a   Gómez, David ^a   De Pablo, Alicia ^a   Lázaro, M Teresa ^a   Carreño, M Cruz ^a   Ferreiro, M José ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b NONE   (Spain)

Author keywords

Lung disease; Lung transplantation; Selection of patients; Spirometry

Indexed keywords

ADULT; ARTICLE; BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HEART FUNCTION; HUMAN; LUNG FIBROSIS; LUNG FUNCTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; SPIROMETRY;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; LUNG DISEASES; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PREOPERATIVE CARE; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 51349094278     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1157/13125380     Document Type: Article

References (23)

1. Salvatierra Velázquez A. Trasplante pulmonar en España. Arch Bronconeumol. 2004;40 Supl 6:41-8.
2. Borro JM. Actualización del trasplante pulmonar en España. Arch Bronconeumol. 2005;41:457-67.
3. Orens JB, Estenne M, Arcasoy S, Conte JV, Corris P, Egan JJ, et al. International guidelines for the selection of lung transplant candidates. J Heart Lung Transplant. 2006;25:745-55.
4. Varela A, Álvarez A, Román A, Ussetti P, Zurbano F. Normativa SEPAR. Trasplante pulmonar. Arch Bronconeumol 2001;37:307-15.
5. Hurst JW, Morris DC, Alexander RW. The use of the New York Heart Association's classification of cardiovascular disease as part of the patient's complete problem list. Clin Cardiol. 1999;22:385-90.
6. Bestall JC, Paul EA, Garrod R, Gambam R, Jones PW, Wedziche JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54:581-6.
7. Celli BR, Cote CG, Marín JM, Casanova C. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:1005-12.
8. Maurer JR, Frost AE, Estenne M, Higenbottam T, Glanville AR. International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society. J Heart Lung Transplant. 1998;17:703-9.
9. Hosenpud JD, Bennet LE, Keck BM, Edwards EB, Novick RJ. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet. 1998;351:24-7.
10. Trulock REP, Edwards LB, Taylor DO, Boucek MM, Keck BM, Hertz MI. Registry of the Internacional Society for Heart and Lung Transplantation: twenty-second official adult lung and heart-lung transplant report-2005. J Heart Lung Transplant. 2005;24: 956-67.
11. Lanuza DM, Lefaiver CA, Farcas GA. Research on the quality of lung transplant candidates and recipients: an integrative review. Heart Lung. 2000;29:180-95.
12. Hanson D, Winterbauer RH, Kirtland SH, Wu R. Changes in pulmonary function test results after one year of therapy as predictors of survival in patients with idiopathic pulmonary fibrosis. Chest. 1995;108:305-10.
13. Brutsche MH, Bishop PW, Greaves SM, Horrocks AW, Egan J. Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation. Am J Respir Crit Care Med. 2001;164:103-8.
14. Collard HR, King TE, Batelson BB, Vourlekis JS, Schwarz MI, Brown KK. Changes and clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2003;168:538-42.
15. De Meester J, Jacqueline M, Smits JMA, Persijn G, Haverich A. Listing for lung transplantation: life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience. J Heart Lung Trasplant. 2001;20:518-24.
16. Reed A, Snell G, McLean C, Williams J. Outcomes of patients with interstitial lung disease referred for lung transplant assessment. Intern Med J. 2006;36:423-30.
17. Aurora P, Wade A, Whitmore P, Whitehead B. A model for predicting life expectancy of children with cystic fibrosis. Eur Respir J. 2000;16:1056-60.
18. Charman S, Sharples L, McNeil K, Wallwork J. Assessment of survival benefit after lung transplantation by patient diagnosis. J Heart Lung Transplant. 2002;21:226-32.
19. Egan T, Detterbeck F, Mill M, Gott K, Rea J, McSweeney J, et al. Lung transplantation for cystic fibrosis: effective and durable therapy in a high-risk group. Ann Thorac Surg. 1998;66:337-46.
20. Padilla J, Calvo V, Jorda C. Fibrosis quística y trasplante pulmonar. Mortalidad perioperatoria. Arch Bronconeumol. 2005;41:489-92.
21. Kerem E, Roseman J, Corey M, Canny GJ, Levison H. Predictors of mortality in patients with cystic fibrosis. N Engl J Med. 1992; 326:1167-91.
22. Liou T, Adler F, Cahill B, Fitzsimmons S, Huang D, Hibbs J, et al. Survival effect of lung transplantation among patients with cystic fibrosis. JAMA. 2001;286:2683-9.
23. De Pablo A, López S, Ussetti P. Trasplante pulmonar en enfermedades supurativas. Arch Bronconeumol. 2005;41:255-9.